Managed Markets
Network

Neutropenia

News

MORE >>>

Combination of Bleomycin and G-CSF Does Not Increase Risk for Bleomycin-Induced Pulmonary Toxicity

Combination of Bleomycin and G-CSF Does Not Increase Risk for Bleomycin-Induced Pulmonary Toxicity

October 17, 2018

Small Benefit Observed When Adding Newly Identified Risk Factors Into Febrile Neutropenia Risk Prediction

October 10, 2018 – Jaime Rosenberg

Earlier Antipseudomonal De-escalation Is a Possibility in AML, Neutropenia

October 08, 2018 – David Bai

Second Biosimilar Approved to Treat Neutropenia

July 24, 2018 – Laura Joszt

Journals

MORE >>>

Perspectives in Febrile Neutropenia: Q&A With Gary Lyman, MD, MPH

December 29, 2017

The Relevance of Febrile Neutropenia in Oncology

December 29, 2017

Pricing and Contracting in Granulocyte Colony Stimulating Factors and Biosimilars for Febrile Neutropenia

December 29, 2017

Conferences

MORE >>>

Diagnosing Congenital Neutropenia

December 23, 2017 – Laura Joszt

Diagnosing Non-Chemotherapy Drug-Induced Neutropenia

December 16, 2017 – Laura Joszt

New Treatment Paradigm Supersedes ABVD in Advanced Hodgkin Lymphoma: The ECHELON-1 Study

December 12, 2017 – Surabhi Dangi-Garimella, PhD

ACCOUNTABLE CARE DELIVERY CONGRESS

CONTINUING EDUCATION

Interactive Tools

Managed Care Podcast

Panel Discussions

Information for Reviewers

Information for Authors

Formulary Central

Clinical Study Summaries

Study Summaries

AJMC Resources

Terms & Conditions

Like Us On Facebook

Follow Us On Twitter

Check us out on LinkedIn

Follow us on Instagram

Subscribe us on YouTube

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.

×

Not a member? Sign up now!